Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)
China flag China · Delayed Price · Currency is CNY
17.03
+0.03 (0.18%)
At close: Feb 3, 2026

SHE:300181 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
692.65804.67931.981,082232.3253.75
Trading Asset Securities
--15110.8365.5261.04
Cash & Short-Term Investments
692.65804.671,0831,093297.82314.79
Cash Growth
-11.91%-25.70%-0.91%266.97%-5.39%126.93%
Accounts Receivable
1,103783.33532.42510.07337.33308.18
Other Receivables
25.0618.189.0224.4226.775.9
Receivables
1,128801.52541.44534.5364.1314.08
Inventory
488.51523.75426.52318.83273.59201.44
Prepaid Expenses
-0-7.87--
Other Current Assets
72.1447.515.535.456.16135.07
Total Current Assets
2,3812,1772,0561,960941.67965.38
Property, Plant & Equipment
1,3771,2201,060972.41806.32750.09
Long-Term Investments
531.36254.64179.7392.36650.67463
Goodwill
130.32130.32130.32130.32130.32130.32
Other Intangible Assets
82.8275.0871.2763.0464.8970.2
Long-Term Deferred Tax Assets
30.8930.425.525.1415.5114.41
Long-Term Deferred Charges
43.5135.5825.4925.4225.623.11
Other Long-Term Assets
66.1468.9178.0774.76113.5553.37
Total Assets
4,6433,9923,6273,6432,7492,470
Accounts Payable
463.95482.41433.85468.88296.77200.63
Accrued Expenses
23.3486.5582.2478.3262.3349.85
Short-Term Debt
610.01377.31193.06138.16178.2302.85
Current Portion of Long-Term Debt
2.97-10.010.01-15.02
Current Portion of Leases
-3.322.492.834.21-
Current Income Taxes Payable
131.7652.5432.6526.5916.467.3
Current Unearned Revenue
7.4214.452.2314.143.061.56
Other Current Liabilities
39.3539.4638.282623.5521.83
Total Current Liabilities
1,2791,056794.83754.94584.58599.04
Long-Term Debt
31.6630.66-10-30.05
Long-Term Leases
17.8718.2716.6922.1324.27-
Long-Term Unearned Revenue
27.2826.519.919.7622.3725.48
Long-Term Deferred Tax Liabilities
10541.0321.6876.24134.195.86
Total Liabilities
1,4611,173853.09883.07765.31750.43
Common Stock
701.39701.39701.39701.39608.62608.62
Additional Paid-In Capital
1,1291,1351,1351,135340.48340.48
Retained Earnings
1,1351,041849.32676.8525.52396.19
Treasury Stock
-122.15-203.97----
Comprehensive Income & Other
274.1294.6342.66190.19369.44257.52
Total Common Equity
3,1172,7692,7292,7041,8441,603
Minority Interest
65.5750.5645.256.18139.15116.63
Shareholders' Equity
3,1832,8192,7742,7601,9831,719
Total Liabilities & Equity
4,6433,9923,6273,6432,7492,470
Total Debt
662.5429.56222.25173.13206.67347.92
Net Cash (Debt)
30.15375.11860.73919.7791.15-33.13
Net Cash Growth
-92.22%-56.42%-6.42%909.09%--
Net Cash Per Share
0.040.541.241.520.15-0.05
Filing Date Shares Outstanding
693.22692.47701.39701.39608.62608.62
Total Common Shares Outstanding
693.22686.49701.39701.39608.62608.62
Working Capital
1,1021,1211,2621,205357.1366.33
Book Value Per Share
4.504.033.893.853.032.63
Tangible Book Value
2,9042,5632,5272,5101,6491,402
Tangible Book Value Per Share
4.193.733.603.582.712.30
Buildings
-1,014962.71832.63678.11660.12
Machinery
-529.12467.55432.59412.82395.27
Construction In Progress
-161.4361.1478.0640.290.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.